Urology: from the daily briefing
Every daily briefing item tagged urology, newest first. The weekly roundup is on the urology page.
- Phase 3 PACE-NODES trial reports early adverse events for pelvic nodal plus prostate SBRT versus prostate-only SBRTEvidence
- Lancet Oncology reports the American Cancer Society's updated prostate cancer screening guidelineEvidence
- AUA and SMSNA amend their guideline on disorders of ejaculationEvidence
- Cretostimogene cut relapse risk 68% versus surveillance in a phase 3 bladder cancer trial, company saysEvidence
- Meta-analysis of 3,320 patients examines who benefits most from first-line checkpoint combinations in kidney cancerEvidence
- American Cancer Society now recommends PSA screening every 2 years from 50 to 69, ending its 2010 shared-decision stanceEvidence
- FDA approves durvalumab plus enfortumab vedotin around cystectomy for cisplatin-ineligible bladder cancerRegulation
- FDA opens a new device class with a robot that removes bladder tumors in one piece through the urethraRegulation
- Starting overactive bladder patients on beta-3 agonists instead of anticholinergics did not lower dementia risk in an 830,393-patient cohortEvidence
- Intuitive says da Vinci procedures grew about 14% in the third quarter and places 546 more systemsMoney
- Prostate MRI AI matches radiology readings for significant cancer in 1,974 external patients across 12 countries, SCARLET-1 study reportsEvidence
Latest news
Tagged urology, from the daily briefing